Drug – bio-affecting and body treating compositions – Immunoglobulin – antiserum – antibody – or antibody fragment,... – Monoclonal antibody or fragment thereof
Reexamination Certificate
2011-04-05
2011-04-05
Ulm, John D (Department: 1649)
Drug, bio-affecting and body treating compositions
Immunoglobulin, antiserum, antibody, or antibody fragment,...
Monoclonal antibody or fragment thereof
C435S334000, C530S388220
Reexamination Certificate
active
07919093
ABSTRACT:
The present application is directed to the identification of mutations and/or polymorphisms in the Dual Endothelin-1/Angiotensin II Receptor (Dear) that indicate susceptibility to, or show current affliction with, hypertension. Additionally, the present invention discloses methods for the modulation of angiogenesis via the regulation of Dear.
REFERENCES:
patent: 5440021 (1995-08-01), Chuntharapai et al.
patent: 6641811 (2003-11-01), Suthanthiran et al.
patent: 2001/0021772 (2001-09-01), Uhlmann
Ruiz-Opazo et al. 2002 Molecular Medicine vol. 8 p. 24.
Ruiz-Opazo et al. (Molecular Medicine 1998 vol. 4 p. 96).
Fujita, M. et al., “Blockade of angiotensin AT1a receptor signaling reduces tumor growth, angiogensis, and metastasis,” Biochemical and Biophysical Research Communications 294:441-447, 2002.
Ruiz-Opazo, N et al., “Molecular Characterization of a Dual Endothelin-1/Angiotensin II Receptor.” Molecular Medicine 4:96-108, 1998.
Kaneko, Y et al., “Sex-specific effects of dual ET-1/ANG II receptor (Dear) variants in Dahl salt-sensitive/resistant hypertension rat model.” Physiol Genomics 20:157-164, 2005.
Glorioso, N et al., “Association of ATP1A1 and Dear Single-Nucleotide Polymorphism Haplotypes With Essential Hypertension Sex-Specific and Haplotype-Specific Effects.” Circ Res. 100:1522-1529, 2007.
Ruiz-Opazo, N. et al., V.L.M. Molecular characterization of a dual endothelin-1/angiotensin II receptor. Molecular Medicine 4, 96-108 (1998).
Kaneko, Y. et al., N. Sex-specific effects of dual ET-1/AngII receptor (Dear) variants in Dahl salt-sensitive/resistant hypertension rat model. Physiol Genomics 20, 157-167 (2005).
Salani, D. et al. Role of endothelin-1 in neovascularization of ovarian carcinoma. Am. J. Pathol. 157, 1537-1547 (2000).
Sullivan, D.C. & Bicknell, R. New molecular pathways in angiogenesis. British Journal of Cancer 89, 228-231 (2003).
Kurihara, Y. et al. Elevated blood pressure and craniofacial abnormalities in mice deficient in endothelin-1. Nature 368, 703-710 (1994).
Clouthier, D.E. et al. Cranial and cardiac neural crest defects in endothelin-A receptor-deficient mice. Development 125,813-824 (1998).
Tanimoto, K. et al. Angiotensinogen-deficient mice with hypotension. J Biol Chem 269, 31334-31337 (1994).
Ito, M. et al. Regulation of blood pressure by the type 1A angiotensin II receptor gene. Pro Natl Acad Sci 92, 3521-3525 (1995).
Chen, X. et al. Targeting deletion of angiotensin type 1B receptor gene in the mouse. Am J Physiol 272, F299-F304 (1997).
Hein, L. et al., Behavioural and cardiovascular effects of disrupting the angiotensin II type 2 receptor in mice. Nature 377, 744-777 (1995).
Carmeliet, P. et al. Abnormal blood vessel development and lethality in embryos lacking a single VEGF allele. Nature 380, 435-439 (1996).
Ferrara, N. et al. Heterozygous embryonic lethality induced by targeted inactivation of the VEGF gene. Nature 380, 439-442 (1996).
Ikeda, T. et al. Pathophysiological roles of endothelin-1 in Dahl salt-sensitive hypertension. Hypertension 34, 514-519 (1999).
Fujita, M. et al. Angiotensin type 1a receptor signaling-dependent induction of vascular endothelial growth factor in stroma is relevant to tumor-associated angiogenesis and tumor growth. Carcinogenesis 26, 271-279 (2005).
Dickson, M.C. et al. Defective haematopoiesis and vasculogenesis in transforming growth factor-b1 knockout mice. Development 121, 1845-1854 (1995).
Herrera, V.L.M. et al. Spontaneous combined hyperlipidemia, coronary heart disease and decreased survival in Dahl salt-sensitive hypertensive rats transgenic for human cholesteryl ester transfer protein. Nature Med 12, 1383-1389 (1999).
Agapitov, A.V. and Haynes, W.G., Role of endothelin in cardiovascular disease. J. Renin Angiotensin Aldosterone Syst. 3: 1-15, 2002.
Elijovich, F. and Laffer, C. L., Participation of renal and circulating endothelin in salt-sensitive essential hypertension. J. Hum. Hypertens. 16: 459-467, 2002.
Garrett, M. R. Genome scan and congenic strains for blood pressure QTL using Dahl Salt sensitive rats. Genome Res. 8:711-723, 1998.
Hausdorff, W. P. et al., A mutation of b2-adrenergic receptor impairs agonist activation of adenylyl cyclase without affecting high affinity agonist binding. Distinct molecular determinants of the receptor are involved in physical coupling to and functional activation of GS. J. Biol. Chem. 265: 1388-1393, 1990.
Herrera, V. L. M. and Ruiz-Opazo, N., Genetics of hypertension: A multidisciplinary challenge. Trends in Cardiovascular Medicine 1: 185-189, 1991
Herrera, V. L. M., et al., The α1 Na,K-ATPase gene is a susceptibility hypertension gene in the Dahl salt-sensitive rat. J. Clin. Invest. 102: 1102-1111, 1998.
Herrera, V. L. M. , et al., αl Na,K-ATPase and Na,K,2Cl-cotransporter/D3Mit3 loci interact to increase susceptibility to salt-sensitive hypertension in Dahl SHSD rats. Molecular Medicine 7: 125-134, 2001.
Iwanaga Y, et al., Differential effects of angiotensin II versus endothelin-1 inhibitions in hypertrophic left ventricular myocardium during transition to heart failure. Circulation 104: 606-612, 2001.
Jeffs B, et al., Applicability of a “speed” congenic strategy to dissect blood pressure quantitative trait loci on rat chromosome 2. Hypertension 35: 179-187, 2000.
Kaneko Y, et al., Corroboration of Dahl S Q276L alpha1-Na,K-ATPase protein sequence: impact on affinities for ligands and on E1 conformation. J Hypertension 23: 745-752, 2005.
Kent RS, et al., A quantitative analysis of beta-adrenergic receptor interactions: resolution of high and low affinity states of the receptor by computer modeling of ligand binding data. Mol. Pharmacol. 17: 14-23, 1980.
Lavallée M et al. Crosstalk between endothelin and nitric oxide in the control of vascular tone. Heart Fail. Rev. 6: 265-276, 2001.
Mukoyama M, et al., Expression cloning of type 2 angiotensin II receptor reveals a unique class of seven transmembrane receptors. J. Biol. Chem. 268: 24539-24542, 1993.
Murphy TJ, et al., Isolation of a cDNA encoding the vascular type-1 angiotensin II receptor. Nature 351: 233-236, 1991.
Nuedling S, et al., 17 Beta-estradiol regulates the expression of endothelin receptor type B in the heart. Br J Pharmacol. 140: 195-201, 2003.
Phalipou S, et al., Docking of linear peptide antagonists into the human V1a vasopressin receptor. J. Biol. Chem. 274: 23316-23327, 1999.
Pravenec M, et al., Mapping of quantitative trait loci for blood pressure and cardiac mass in the rat by genome scanning of recombinant inbred strains. J. Clin. Invest. 96: 1973-1978, 1995.
Rapp JP. Genetic analysis of inherited hypertension in the rat. Physiological Reviews 80: 135-172, 2000.
Romero JC and Reckelhoff JF. Role of angiotensin and oxidative stress in essential hypertension. Hypertension 34: 943-949, 1999.
Ruiz-Opazo N., et al., Identification of a novel dual AngiotensinII/Vasopressin receptor on the basis of molecular recognition theory. Nature Medicine 1: 1074-1081, 1995.
Ruiz-Opazo N., et al., The dual AngII/AVP receptor gene N119S/C163R variant exhibits sodium-induced dysfunction and cosegregates with salt-sensitive hypertension in the Dahl salt-sensitive hypertensive rat model. Molecular Medicine 8: 24-32, 2002.
Song Y, et al., Non-association of the thiazide-sensitive Na,Cl-cotransporter gene with polygenic hypertension in both rats and humans. J. Hypertension 19: 1547-1551, 2001.
Tsukamoto T, et al., Isolation and characterization of the yeast mRNA capping enzyme beta subunit gene encoding RNA 5′-triphosphatase, which is essential for cell viability. Biochem. Biophy. Res. Commun. 239: 116-122, 1997.
Richardson JC, et al., Ultrastructural and behavioural changes precede amyloid deposition in a transgenic model of Alzheimer's disease. Neuroscience 122: 213-228 (2003).
Kaneko Y, et al., Sex-specific effects of dual ET-1/AngII receptor (Dear) variants in Dahl salt-sensitive/resistant hypertension rat model. Physiol Genomics Nov. 23; [Epub ahead of print], (2004).
Long BJ, et al., Therapeutic strategies using the ar
Herrera Victoria L. M.
Ruiz-Opazo Nelson
Nixon & Peabody LLP
Trustees of Boston University
Ulm John D
LandOfFree
Roles for dual endothelin-1/angiotensin II receptor (Dear)... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Roles for dual endothelin-1/angiotensin II receptor (Dear)..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Roles for dual endothelin-1/angiotensin II receptor (Dear)... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-2630368